New immune cell therapy tested for tough bladder cancers
NCT ID NCT07204496
Summary
This study is testing a new type of treatment called γδ-T cell injection for people with advanced bladder cancer that hasn't responded to other therapies. About 20-29 patients will receive infusions of these specially prepared immune cells to see if they can slow or stop the cancer's growth and improve quality of life. The main goal is to see if this therapy is safe and can help patients live longer without their cancer getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.